Friedegund Meier Selected Research

Friedegund Meier Research Topics

Disease

105	Melanoma (Melanoma, Malignant) 05/2024 - 04/2003
47	Neoplasms (Cancer) 05/2024 - 10/2003
32	Neoplasm Metastasis (Metastasis) 04/2024 - 04/2003
20	Skin Neoplasms (Skin Cancer) 12/2023 - 01/2016
11	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2013
8	Uveal melanoma 10/2023 - 11/2019
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2024 - 01/2020
4	Disease Progression 07/2023 - 04/2016
3	Merkel Cell Carcinoma 01/2023 - 10/2017
2	Infections 02/2023 - 01/2021
2	Encephalitis (Encephalitis, Rasmussen) 12/2022 - 11/2022
2	Glioma (Gliomas) 12/2022 - 11/2022
2	Pancreatitis 01/2021 - 01/2018
2	Pneumonia (Pneumonitis) 02/2019 - 10/2014
2	Lymphatic Metastasis 02/2019 - 06/2011
1	Body Weight (Weight, Body) 11/2023
1	Hypophysitis 11/2023
1	Cardiomyopathies (Cardiomyopathy) 11/2023
1	Wounds and Injuries (Trauma) 02/2023
1	Hypotension (Low Blood Pressure) 01/2023
1	Fever (Fevers) 01/2023
1	Cytokine Release Syndrome 01/2023
1	Leukocytosis (Pleocytosis) 11/2022

Drug/Important Bio-Agent (IBA)

39	Immune Checkpoint InhibitorsIBA 12/2023 - 01/2017
20	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2023 - 09/2005
14	VemurafenibIBA 12/2023 - 11/2012
12	IpilimumabIBA 10/2022 - 12/2015
11	NivolumabIBA 10/2023 - 01/2016
10	Biomarkers (Surrogate Marker)IBA 05/2024 - 11/2016
10	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2023 - 04/2003
10	pembrolizumabIBA 05/2023 - 01/2016
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2003
9	AntibodiesIBA 05/2023 - 01/2016
6	Mitogen-Activated Protein KinasesIBA 12/2023 - 02/2011
5	CytokinesIBA 01/2023 - 05/2003
4	cemiplimabIBA 03/2024 - 01/2020
4	trametinibIBA 12/2023 - 10/2018
4	Programmed Cell Death 1 ReceptorIBA 12/2021 - 01/2017
4	Antineoplastic Agents (Antineoplastics)IBA 12/2016 - 08/2006
3	encorafenibIBA 12/2023 - 10/2022
3	dabrafenibIBA 12/2023 - 12/2015
3	AntigensIBA 12/2023 - 06/2003
3	tebentafuspIBA 06/2023 - 01/2023
3	Phosphotransferases (Kinase)IBA 01/2023 - 07/2011
3	Proto-Oncogene Proteins B-rafIBA 03/2021 - 01/2013
3	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 03/2021 - 11/2013
3	LigandsIBA 03/2015 - 07/2004
2	binimetinibIBA 12/2023 - 11/2023
2	cobimetinibIBA 12/2023 - 11/2023
2	bempegaldesleukinIBA 10/2023 - 01/2020
2	tremelimumabIBA 01/2023 - 01/2019
2	CTLA-4 AntigenIBA 01/2023 - 03/2018
2	B7-H1 AntigenIBA 01/2023 - 03/2018
2	Leucine (L-Leucine)FDA Link 12/2022 - 11/2022
2	Cadherins (E-Cadherin)IBA 11/2022 - 09/2005
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 12/2021
2	NVP-BKM120IBA 01/2020 - 12/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2019 - 04/2018
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2017 - 08/2006
2	Temozolomide (Temodar)FDA LinkGeneric 01/2017 - 06/2009
2	Conditioned Culture MediaIBA 12/2016 - 02/2013
2	Tumor Biomarkers (Tumor Markers)IBA 10/2013 - 04/2003
2	Cisplatin (Platino)FDA LinkGeneric 06/2009 - 05/2007
2	Integrin alphaVbeta3IBA 08/2006 - 09/2005
1	Peptide Hydrolases (Proteases)FDA Link 05/2024
1	Cytokine Receptors (Cytokine Receptor)IBA 04/2024
1	Infliximab (Remicade)FDA Link 03/2024
1	SteroidsIBA 03/2024
1	Immunosuppressive Agents (Immunosuppressants)IBA 03/2024
1	Immunoglobulins (Immunoglobulin)IBA 03/2024
1	RNA (Ribonucleic Acid)IBA 12/2023
1	tributyl phosphate (TBP)IBA 11/2023
1	PotassiumIBA 11/2023
1	MicroRNAs (MicroRNA)IBA 10/2023
1	Hematoxylin (Haematoxylon)IBA 07/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2023
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2023
1	HLA-A Antigens (HLA-A)IBA 01/2023
1	cyclopropapyrroloindoleIBA 01/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	durvalumabIBA 01/2023
1	Monomeric GTP-Binding ProteinsIBA 01/2023
1	EpitopesIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	MART-1 AntigenIBA 12/2021
1	Interferon-gamma (Interferon, gamma)IBA 12/2021
1	Peptide LibraryIBA 12/2021
1	SDMIBA 04/2021
1	C-PeptideIBA 01/2021

Therapy/Procedure

72	Therapeutics 05/2024 - 06/2003
15	Immunotherapy 10/2023 - 01/2013
10	Radiotherapy 10/2022 - 05/2013
4	Drug Therapy (Chemotherapy) 10/2017 - 05/2009
2	Surgical Amputation (Amputations) 11/2023 - 02/2023
2	Aftercare (After-Treatment) 06/2021 - 05/2009
2	Lymph Node Excision (Lymph Node Dissection) 08/2013 - 01/2010
1	Palliative Care (Palliative Therapy) 07/2023
1	Terminal Care (Care, Terminal) 07/2023
1	Neoadjuvant Therapy 10/2022
1	Withholding Treatment 05/2021